Benitec Biopharma (BNTC) Return on Equity (2020 - 2025)
Historic Return on Equity for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to 0.11%.
- Benitec Biopharma's Return on Equity rose 14800.0% to 0.11% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.11%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 0.91% for FY2024, which is 114900.0% up from last year.
- Benitec Biopharma's Return on Equity amounted to 0.11% in Q1 2025, which was up 14800.0% from 0.14% recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Return on Equity ranged from a high of 0.11% in Q1 2025 and a low of 7.78% during Q2 2023
- In the last 5 years, Benitec Biopharma's Return on Equity had a median value of 1.32% in 2021 and averaged 1.73%.
- As far as peak fluctuations go, Benitec Biopharma's Return on Equity crashed by -43400bps in 2023, and later soared by 70400bps in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's Return on Equity stood at 1.32% in 2021, then dropped by -19bps to 1.56% in 2022, then rose by 26bps to 1.15% in 2023, then soared by 88bps to 0.14% in 2024, then increased by 17bps to 0.11% in 2025.
- Its last three reported values are 0.11% in Q1 2025, 0.14% for Q4 2024, and 0.38% during Q3 2024.